Changes in karyotype and azole susceptibility of sequential bloodstream isolates from patients with Candida glabrata candidemia

Journal of Clinical Microbiology

Volumn 45, Issue 8, 2007, Pages 2385-2391

  Jong, Hee Shin ^a   Myung, Jong Chae ^a   Jeong, Won Song ^a   Jung, Sook In ^a   Cho, Duck ^a   Seung, Jung Kee ^a   Soo, Hyun Kim ^a   Myung, Geun Shin ^a   Soon, Pal Suh ^a   Dong, Wook Ryang ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA GLABRATA; CANDIDEMIA; CGCDR1 GENE; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; FUNGAL GENE; FUNGAL STRAIN; FUNGEMIA; FUNGUS ISOLATION; GENE EXPRESSION; GENOTYPE; HUMAN; KARYOTYPE; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; AZOLES; CANDIDA GLABRATA; CANDIDIASIS; CHILD, PRESCHOOL; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; FUNGEMIA; GENOTYPE; HUMANS; KARYOTYPING; LONGITUDINAL STUDIES; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA;

CANDIDA GLABRATA;

EID: 34548063484     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00381-07     Document Type: Article

References (28)

1. Asakura, K., S. Iwaguchi, M. Homma, T. Sukai, K. Higashide, and K. Tanaka. 1991. Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrata. J. Gen. Microbiol. 137:2531-2539.
2. Barchiesi, F., L. Falconi Di Francesco, D. Arzeni, F. Caselli, D. Gallo, and G. Scalise. 1999. Electrophoretic karyotyping and triazole susceptibility of Candida glabrata clinical isolates. Eur. J. Clin. Microbiol. Infect. Dis. 18:184-187.
3. Barton, R. C., A. van Belkum, and S. Scherer. 1995. Stability of karyotype in serial isolates of Candida albicans from neutropenic patients. J. Clin. Microbiol. 33:794-796.
4. Bennett, J. E., K. Izumikawa, and K. A. Marr. 2004. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Antimicrob. Agents Chemother. 48:1773-1777.
5. Borst, A., M. T. Raimer, D. W. Warnock, C. J. Morrison, and B. A. Arthington-Skaggs. 2005. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole. Antimicrob. Agents Chemother. 49:783-787.
6. Brockert, P. J., S. A. Lachke, T. Srikantha, C. Pujol, R. Galask, and D. R. Soil. 2003. Phenotypic switching and mating type switching of Candida glabrata at sites of colonization. Infect. Immun. 71:7109-7118.
7. Cormican, M. G., R. J. Hollis, and M. A. Pfaller. 1996. DNA macrorestriction profiles and antifungal susceptibility of Candida (Torulopsis) glabrata. Diagn. Microbiol. Infect. Dis. 25:83-87.
8. Cowen, L. E., D. Sanglard, D. Calabrese, C. Sirjusingh, J. B. Anderson, and L. M. Kohn. 2000. Evolution of drug resistance in experimental populations of Candida albicans. J. Bacteriol. 182:1515-1522.
9. Dodgson, A. R., C. Pujol, D. W. Denning, D. R. Soll, and A. J. Fox. 2003. Multilocus sequence typing of Candida glabrata reveals geographically enriched clades. J. Clin. Microbiol. 41:5709-5717.
10. Fidel, P. L., Jr., J. A. Vazquez, and J. D. Sobel. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin. Microbiol. Rev. 12:80-96.
11. Hajjeh, R. A., A. N. Sofair, L. H. Harrison, G. M. Lyon, B. A. Arthington-Skaggs, S. A. Mirza, M. Phelan, J. Morgan, W. Lee-Yang, M. A. Ciblak, L. E. Benjamin, L. T. Sanza, S. Huie, S. F. Yeo, M. E. Brandt, and D. W. Warnock. 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol. 42:1519-1527.
12. Kaufmann, C. S., and W. G. Merz. 1989. Electrophoretic karyotypes of Torulopsis glabrata. J. Clin. Microbiol. 27:2165-2168.
13. Klein, H. L. 2001. Spontaneous chromosome loss in Saccharomyces cerevisiae is suppressed by DNA damage checkpoint functions. Genetics 159:1501-1509.
14. Klempp-Selb, B., D. Rimek, and R. Kappe. 2000. Karyotyping of Candida albicans and Candida glabrata from patients with Candida sepsis. Mycoses 43:159-163.
15. Magill, S. S., C. Shields, C. L. Sears, M. Choti, and W. G. Merz. 2006. Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy. J. Clin. Microbiol. 44:529-535.
16. Marichal, P., H. Vanden Bossche, F. C. Odds, G. Nobels, D. W. Warnock, V. Timmerman, C. Van Broeckhoven, S. Fay, and P. Mose-Larsen. 1997. Molecular biological characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 41:2229-2237.
17. National Committee for Clinical Laboratory Standards/CLSI. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
18. Pfaller, M. A., and D. J. Diekema. 2004. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 42:4419-4431.
19. Pfaller, M. A., S. A. Messer, L. Boyken, S. Tendolkar, R. J. Hollis, and D. J. Diekema. 2004. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J. Clin. Microbiol. 42:3142-3146.
20. Ramsey, H., B. Morrow, and D. R. Soll. 1994. An increase in switching frequency correlates with an increase in recombination of the ribosomal chromosomes of Candida albicans strain 3153A. Microbiology 140:1525-1531.
21. Redding, S. W., W. R. Kirkpatrick, S. Saville, B. J. Coco, W. White, A. Fothergill, M. Rinaldi, T. Eng, T. F. Patterson, and J. Lopez-Ribot. 2003. Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation. J. Clin. Microbiol. 41:619-622.
22. Sanglard, D., F. Ischer, D. Calabrese, P. A. Majcherczyk, and J. Bille. 1999. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob. Agents Chemother. 43:2753-2765.
23. Sanguinetti, M., B. Posteraro, B. Fiori, S. Ranno, R. Torelli, and G. Fadda. 2005. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob. Agents Chemother. 49:668-679.
24. Shin, J. H., D. H. Shin, J. W. Song, S. J. Kee, S. P. Suh, and D. W. Ryang. 2001. Electrophoretic karyotype analysis of sequential Candida parapsilosis isolates from patients with persistent or recurrent fungemia. J. Clin. Microbiol. 39:1258-1263.
25. Shin, J. H., M. R. Park, J. W. Song, D. H. Shin, S. I. Jung, D. Cho, S. J. Kee, M. G. Shin, S. P. Suh, and D. W. Ryang. 2004. Microevolution of Candida albicans strains during catheter-related candidemia. J. Clin. Microbiol. 42:4025-4031.
26. Soll, D. R. 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev. 13:332-370.
27. Srikantha, T., R. Zhao, K. Daniels, J. Radke, and D. R. Soll. 2005. Phenotypic switching in Candida glabrata accompanied by changes in expression of genes with deduced functions in copper detoxification and stress. Eukaryot. Cell 4:1434-1445.
28. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.